US Stock MarketDetailed Quotes

IART Integra Lifesciences

Watchlist
  • 31.530
  • +0.110+0.35%
Close Jul 25 16:00 ET
  • 31.530
  • 0.0000.00%
Post 20:01 ET
2.48BMarket Cap61.82P/E (TTM)

Integra Lifesciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-39.76%15.76M
-47.08%139.96M
-31.15%58.75M
-60.81%26.77M
-57.46%28.28M
-41.02%26.16M
-15.35%264.47M
23.18%85.33M
-17.48%68.31M
-27.18%66.48M
Net income from continuing operations
-113.54%-3.28M
-62.48%67.74M
-62.54%19.83M
-60.94%19.5M
-90.66%4.18M
-26.37%24.23M
6.79%180.55M
16.66%52.95M
15.47%49.92M
27.72%44.79M
Operating gains losses
152.17%12K
110.42%777K
110.11%781K
121.65%100K
-505.00%-81K
-103.23%-23K
81.15%-7.46M
-2,133.42%-7.73M
-121.26%-462K
-97.39%20K
Depreciation and amortization
-1.85%30.57M
4.41%123.51M
5.05%30.99M
3.70%30.56M
4.10%30.83M
4.77%31.14M
-1.28%118.3M
-4.07%29.5M
-2.17%29.47M
-0.48%29.61M
Deferred tax
-246.24%-2.86M
-159.21%-11.89M
-146.48%-14.85M
120.27%1.24M
-105.68%-227K
-44.89%1.95M
-66.42%-4.59M
-156.07%-6.02M
28.96%-6.1M
208.85%4M
Other non cash items
-74.48%2M
299.58%21.24M
831.71%6.11M
138.73%3.98M
268.56%3.3M
733.23%7.85M
-222.31%-10.64M
-21.81%656K
-578.15%-10.29M
-189.40%-1.96M
Change In working capital
45.20%-23.35M
-106.94%-81.57M
-1.59%10.09M
-969.18%-34.06M
10.34%-14.99M
-43.14%-42.61M
-317.03%-39.42M
140.62%10.26M
-153.55%-3.19M
-245.56%-16.72M
-Change in receivables
67.58%16.83M
113.55%4.59M
95.45%-457K
101.57%224K
19.97%-5.22M
422.24%10.04M
-566.69%-33.91M
1.35%-10.04M
-314.59%-14.24M
-9.44%-6.52M
-Change in inventory
25.18%-19.02M
-105.24%-59.77M
-250.84%-16.42M
-130.01%-15.8M
64.56%-2.13M
-119.90%-25.42M
-641.94%-29.12M
-152.17%-4.68M
-5.79%-6.87M
-215.12%-6.02M
-Change in prepaid assets
-23.66%-2.68M
-69.21%2.65M
248.73%24.35M
-294.61%-11.19M
-1,001.51%-8.35M
57.11%-2.16M
140.73%8.61M
173.92%6.98M
258.16%5.75M
120.64%926K
-Change in payables and accrued expense
-285.43%-19.21M
-216.64%-20.23M
-89.46%1.91M
-145.39%-6.24M
-127.30%-10.92M
48.90%-4.98M
-47.24%17.34M
1,944.11%18.15M
108.98%13.75M
-137.43%-4.8M
-Change in other current assets
105.64%339K
-291.15%-8.54M
102.03%239K
-120.80%-590K
-148.82%-2.18M
-363.21%-6.01M
-127.71%-2.18M
-695.29%-11.76M
54.77%2.84M
170.14%4.46M
-Change in other current liabilities
113.02%1.89M
90.76%-410K
-95.10%483K
101.78%110K
343.59%13.5M
-463.00%-14.5M
68.55%-4.44M
163.06%9.85M
-700.78%-6.17M
-154.63%-5.54M
-Change in other working capital
-448.37%-1.5M
-97.01%128K
-100.74%-13K
-133.31%-583K
--294K
--430K
15,164.29%4.27M
--1.75M
--1.75M
----
Cash from discontinued investing activities
Operating cash flow
-39.76%15.76M
-47.08%139.96M
-31.15%58.75M
-60.81%26.77M
-57.46%28.28M
-41.02%26.16M
-15.35%264.47M
23.18%85.33M
-17.48%68.31M
-27.18%66.48M
Investing cash flow
Cash flow from continuing investing activities
-293.79%-53.97M
-60.77%-94.18M
-4.39%-57.23M
-151.99%-7.7M
-245.66%-15.55M
2.58%-13.7M
63.71%-58.58M
-99.45%-54.82M
274.69%14.81M
43.19%-4.5M
Net PPE purchase and sale
-12.85%-15.47M
-114.32%-66.87M
-641.01%-24.54M
-42.85%-13.08M
-65.28%-15.55M
-46.96%-13.7M
35.03%-31.2M
87.93%-3.31M
-25.70%-9.16M
-41.80%-9.41M
Net intangibles purchase and sale
----
--0
--0
--0
----
----
-8,075.86%-4.74M
--0
--0
--0
Net business purchase and sale
----
--0
--0
----
----
----
75.72%-27.55M
---51.51M
----
----
Net investment purchase and sale
---38.5M
-656.39%-27.31M
---32.69M
--5.38M
--0
--0
6,359.21%4.91M
--0
--0
----
Cash from discontinued investing activities
Investing cash flow
-293.79%-53.97M
-60.77%-94.18M
-4.39%-57.23M
-151.99%-7.7M
-245.66%-15.55M
2.58%-13.7M
63.71%-58.58M
-99.45%-54.82M
274.69%14.81M
43.19%-4.5M
Financing cash flow
Cash flow from continuing financing activities
320.48%358.68M
8.74%-229.93M
92.95%-6.89M
-549.82%-49.66M
18.67%-10.69M
-21.89%-162.68M
-156.50%-251.95M
-18,852.21%-97.7M
-538.44%-7.64M
86.51%-13.15M
Net issuance payments of debt
16,254.55%355.4M
150.56%54.5M
93.58%-6.5M
1,252.31%74.9M
-2,440.00%-11.7M
-340.00%-2.2M
-7.80%-107.8M
-12,762.50%-101.3M
-712.50%-6.5M
100.51%500K
Net common stock issuance
--0
-120.00%-275M
--0
---125M
--0
-20.00%-150M
---125M
--0
--0
--0
Proceeds from stock option exercised by employees
175.06%6.4M
-21.01%4.32M
-94.19%225K
--655K
214.73%1.11M
87.73%2.33M
-19.92%5.47M
1,541.10%3.87M
--0
-74.44%353K
Net other financing activities
75.63%-3.12M
44.18%-13.74M
-126.10%-615K
81.26%-214K
99.26%-104K
-39.17%-12.81M
-387.49%-24.62M
47.18%-272K
-158.37%-1.14M
-2,970.18%-14M
Cash from discontinued financing activities
Financing cash flow
320.48%358.68M
8.74%-229.93M
92.95%-6.89M
-549.82%-49.66M
18.67%-10.69M
-21.89%-162.68M
-156.50%-251.95M
-18,852.21%-97.7M
-538.44%-7.64M
86.51%-13.15M
Net cash flow
Beginning cash position
-39.47%276.4M
-11.06%456.66M
-46.53%273.73M
-30.85%309.19M
-24.50%307.37M
-11.06%456.66M
9.21%513.45M
8.87%511.94M
12.52%447.15M
-0.46%407.09M
Current changes in cash
313.32%320.47M
-299.77%-184.15M
92.01%-5.37M
-140.52%-30.59M
-95.83%2.04M
-45.59%-150.23M
-187.31%-46.06M
-258.78%-67.19M
-0.75%75.48M
446.28%48.83M
Effect of exchange rate changes
-629.67%-4.96M
136.27%3.89M
-32.50%8.04M
54.41%-4.87M
97.57%-213K
129.58%937K
-13.16%-10.72M
1,217.37%11.91M
-230.99%-10.69M
-445.39%-8.77M
End cash Position
92.57%591.91M
-39.47%276.4M
-39.47%276.4M
-46.53%273.73M
-30.85%309.19M
-24.50%307.37M
-11.06%456.66M
-11.06%456.66M
8.87%511.94M
12.52%447.15M
Free cash flow
-97.66%291K
-66.38%73.09M
-51.73%34.22M
-76.86%13.69M
-77.69%12.73M
-58.87%12.45M
-17.77%217.38M
69.60%70.88M
-21.64%59.16M
-32.58%57.07M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -39.76%15.76M-47.08%139.96M-31.15%58.75M-60.81%26.77M-57.46%28.28M-41.02%26.16M-15.35%264.47M23.18%85.33M-17.48%68.31M-27.18%66.48M
Net income from continuing operations -113.54%-3.28M-62.48%67.74M-62.54%19.83M-60.94%19.5M-90.66%4.18M-26.37%24.23M6.79%180.55M16.66%52.95M15.47%49.92M27.72%44.79M
Operating gains losses 152.17%12K110.42%777K110.11%781K121.65%100K-505.00%-81K-103.23%-23K81.15%-7.46M-2,133.42%-7.73M-121.26%-462K-97.39%20K
Depreciation and amortization -1.85%30.57M4.41%123.51M5.05%30.99M3.70%30.56M4.10%30.83M4.77%31.14M-1.28%118.3M-4.07%29.5M-2.17%29.47M-0.48%29.61M
Deferred tax -246.24%-2.86M-159.21%-11.89M-146.48%-14.85M120.27%1.24M-105.68%-227K-44.89%1.95M-66.42%-4.59M-156.07%-6.02M28.96%-6.1M208.85%4M
Other non cash items -74.48%2M299.58%21.24M831.71%6.11M138.73%3.98M268.56%3.3M733.23%7.85M-222.31%-10.64M-21.81%656K-578.15%-10.29M-189.40%-1.96M
Change In working capital 45.20%-23.35M-106.94%-81.57M-1.59%10.09M-969.18%-34.06M10.34%-14.99M-43.14%-42.61M-317.03%-39.42M140.62%10.26M-153.55%-3.19M-245.56%-16.72M
-Change in receivables 67.58%16.83M113.55%4.59M95.45%-457K101.57%224K19.97%-5.22M422.24%10.04M-566.69%-33.91M1.35%-10.04M-314.59%-14.24M-9.44%-6.52M
-Change in inventory 25.18%-19.02M-105.24%-59.77M-250.84%-16.42M-130.01%-15.8M64.56%-2.13M-119.90%-25.42M-641.94%-29.12M-152.17%-4.68M-5.79%-6.87M-215.12%-6.02M
-Change in prepaid assets -23.66%-2.68M-69.21%2.65M248.73%24.35M-294.61%-11.19M-1,001.51%-8.35M57.11%-2.16M140.73%8.61M173.92%6.98M258.16%5.75M120.64%926K
-Change in payables and accrued expense -285.43%-19.21M-216.64%-20.23M-89.46%1.91M-145.39%-6.24M-127.30%-10.92M48.90%-4.98M-47.24%17.34M1,944.11%18.15M108.98%13.75M-137.43%-4.8M
-Change in other current assets 105.64%339K-291.15%-8.54M102.03%239K-120.80%-590K-148.82%-2.18M-363.21%-6.01M-127.71%-2.18M-695.29%-11.76M54.77%2.84M170.14%4.46M
-Change in other current liabilities 113.02%1.89M90.76%-410K-95.10%483K101.78%110K343.59%13.5M-463.00%-14.5M68.55%-4.44M163.06%9.85M-700.78%-6.17M-154.63%-5.54M
-Change in other working capital -448.37%-1.5M-97.01%128K-100.74%-13K-133.31%-583K--294K--430K15,164.29%4.27M--1.75M--1.75M----
Cash from discontinued investing activities
Operating cash flow -39.76%15.76M-47.08%139.96M-31.15%58.75M-60.81%26.77M-57.46%28.28M-41.02%26.16M-15.35%264.47M23.18%85.33M-17.48%68.31M-27.18%66.48M
Investing cash flow
Cash flow from continuing investing activities -293.79%-53.97M-60.77%-94.18M-4.39%-57.23M-151.99%-7.7M-245.66%-15.55M2.58%-13.7M63.71%-58.58M-99.45%-54.82M274.69%14.81M43.19%-4.5M
Net PPE purchase and sale -12.85%-15.47M-114.32%-66.87M-641.01%-24.54M-42.85%-13.08M-65.28%-15.55M-46.96%-13.7M35.03%-31.2M87.93%-3.31M-25.70%-9.16M-41.80%-9.41M
Net intangibles purchase and sale ------0--0--0---------8,075.86%-4.74M--0--0--0
Net business purchase and sale ------0--0------------75.72%-27.55M---51.51M--------
Net investment purchase and sale ---38.5M-656.39%-27.31M---32.69M--5.38M--0--06,359.21%4.91M--0--0----
Cash from discontinued investing activities
Investing cash flow -293.79%-53.97M-60.77%-94.18M-4.39%-57.23M-151.99%-7.7M-245.66%-15.55M2.58%-13.7M63.71%-58.58M-99.45%-54.82M274.69%14.81M43.19%-4.5M
Financing cash flow
Cash flow from continuing financing activities 320.48%358.68M8.74%-229.93M92.95%-6.89M-549.82%-49.66M18.67%-10.69M-21.89%-162.68M-156.50%-251.95M-18,852.21%-97.7M-538.44%-7.64M86.51%-13.15M
Net issuance payments of debt 16,254.55%355.4M150.56%54.5M93.58%-6.5M1,252.31%74.9M-2,440.00%-11.7M-340.00%-2.2M-7.80%-107.8M-12,762.50%-101.3M-712.50%-6.5M100.51%500K
Net common stock issuance --0-120.00%-275M--0---125M--0-20.00%-150M---125M--0--0--0
Proceeds from stock option exercised by employees 175.06%6.4M-21.01%4.32M-94.19%225K--655K214.73%1.11M87.73%2.33M-19.92%5.47M1,541.10%3.87M--0-74.44%353K
Net other financing activities 75.63%-3.12M44.18%-13.74M-126.10%-615K81.26%-214K99.26%-104K-39.17%-12.81M-387.49%-24.62M47.18%-272K-158.37%-1.14M-2,970.18%-14M
Cash from discontinued financing activities
Financing cash flow 320.48%358.68M8.74%-229.93M92.95%-6.89M-549.82%-49.66M18.67%-10.69M-21.89%-162.68M-156.50%-251.95M-18,852.21%-97.7M-538.44%-7.64M86.51%-13.15M
Net cash flow
Beginning cash position -39.47%276.4M-11.06%456.66M-46.53%273.73M-30.85%309.19M-24.50%307.37M-11.06%456.66M9.21%513.45M8.87%511.94M12.52%447.15M-0.46%407.09M
Current changes in cash 313.32%320.47M-299.77%-184.15M92.01%-5.37M-140.52%-30.59M-95.83%2.04M-45.59%-150.23M-187.31%-46.06M-258.78%-67.19M-0.75%75.48M446.28%48.83M
Effect of exchange rate changes -629.67%-4.96M136.27%3.89M-32.50%8.04M54.41%-4.87M97.57%-213K129.58%937K-13.16%-10.72M1,217.37%11.91M-230.99%-10.69M-445.39%-8.77M
End cash Position 92.57%591.91M-39.47%276.4M-39.47%276.4M-46.53%273.73M-30.85%309.19M-24.50%307.37M-11.06%456.66M-11.06%456.66M8.87%511.94M12.52%447.15M
Free cash flow -97.66%291K-66.38%73.09M-51.73%34.22M-76.86%13.69M-77.69%12.73M-58.87%12.45M-17.77%217.38M69.60%70.88M-21.64%59.16M-32.58%57.07M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Brain-computer Interface
Brain-computer Interface
Intraday-1.32%